[1] |
Wong TY, Scott IU. Retinal-Vein Occlusion[J]. New England Journal of Medicine, 2010, 363(22):2135-2144.
|
[2] |
Wang Q, Li T, Wu Z, et al. Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo[J]. Plos One, 2013, 8(8):e70544.
|
[3] |
Yoshioka E, Yamaguchi M, Shiraishi A, et al. Influence of Eyelid Pressure on Fluorescein Staining of Ocular Surface in Dry Eyes.[J]. Am J Ophthalmol, 2015, 160(4):685-692.
|
[4] |
Rehak J, Rehak M. Branch Retinal Vein Occlusion: Pathogenesis, Visual Prognosis, and Treatment Modalities[J]. Current Eye Research, 2008, 33(2):111-131.
|
[5] |
陈甲兴,唐宁. 视网膜静脉阻塞相关因素的临床观察[J]. 国际眼科杂志,2014,14(2):354-357.
|
[6] |
张惠蓉,夏英杰. 视网膜静脉阻塞患者视力预后相关因素分析[J]. 中华眼科杂志,2002,38(2):98-102.
|
[7] |
张惠蓉,王欣,鹿新荣,等. 视网膜静脉阻塞致黄斑水肿患者相干光断层扫描和视力预后观察[J]. 中华眼科杂志,2005,41(10):910-916.
|
[8] |
Bhisitkul RB, Campochiaro PA, Shapiro H, et al. Predictive value in retinal vein occlusions of early versus late or incomplete ranibizumab response defined by optical coherence tomography[J]. Ophthalmology, 2013, 120(5):1057-1063.
|
[9] |
Wroblewski JJ, Rd WJ, Gonzales CR. Pegaptanib sodium for macular edema secondary to branch retinal vein occlusion[J]. Am J Ophthalmol, 2009, 127(4):374-380.
|
[10] |
严密,廖菊生. 视网膜静脉阻塞认识和治疗方法的争议[J]. 中华眼底病杂志,2007,23(3):55-158.
|
[11] |
The Branch Vein Occlusion Study Group. Argon laser photocoagulation for macular edema in branch vein occlusion[J]. Am J Ophthalmol, 1984, 98(3):271-282.
|
[12] |
白石. 不同方法治疗视网膜分支静脉阻塞继发黄斑水肿的疗效[J]. 国际眼科杂志,2017,17(4):648-651.
|
[13] |
Arnarsson A, Stefánsson E. Laser treatment and the mechanism of edema reduction in branch retinal vein occlusion[J]. Invest Ophthalmol Vis Sci, 2000, 41(3):877-879.
|
[14] |
王文吉. 视网膜静脉阻塞[J]. 中国眼耳鼻喉科杂志,2012,12(2):78-81.
|
[15] |
The Central Vein Occlusion Study Group M report. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion[J]. Ophthalmology, 1995, 102(10):1425-1433.
|
[16] |
刘卫. 视网膜静脉阻塞继发黄斑水肿的治疗进展[J]. 中华眼底病杂志,2013,29(6):785-788.
|
[17] |
Domalpally A, Blodi BA, Scott IU, et al. A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Observation to Treat Vision Loss Associated With Macular Edema Secondary to Central Retinal Vein Occlusion[J]. Evidence-Based Ophthalmology, 2009, 11(1):22-23.
|
[18] |
何勤,王林,柯根杰,等. 康柏西普单次玻璃体腔注射治疗视网膜静脉阻塞伴黄斑水肿[J]. 实用防盲技术,2016,11(2):69-71.
|
[19] |
Yeh WS, Haller JA, Lanzetta P, et al. Effect of the Duration of Macular Edema on Clinical Outcomes in Retinal Vein Occlusion Treated with Dexamethasone Intravitreal Implant[J]. Ophthalmology, 2012, 119(6):1190-1198.
|
[20] |
Le MO, Duncombe A, Portmann A, et al. Role of intravitreal bevacizumab for resistant macular edema due to central retinal vein occlusion after failure of intravitreal triamcinolone acetonide.[J]. Journal Franais Dophtalmologie, 2012, 35(9):700-704.
|
[21] |
张菁,蔡小军,陈晓敏,等. 玻璃体腔注射康柏西普联合视网膜激光光凝治疗视网膜分支静脉阻塞继发黄斑水肿疗效观察[J]. 中华眼底病杂志,2015,31(1):22-26.
|
[22] |
Tan MH, McAllister IL, Gillies ME, et al. Randomized controlled trial of intravitreal ranibizumab versus standard grid laser for macular edema following branch retinal vein occlusion[J]. Am J Ophthalmol, 2014, 157(1):237-247.
|
[23] |
杨林红,皇甫昌涛,朱琳,等. 眼内注射康柏西普治疗视网膜分支静脉阻塞继发黄斑水肿的临床观察[J]. 昆明医科大学学报,2015,36(11):147-149.
|
[24] |
Alon T, Hemo I, Itin A, et al. Vascular endothelial growth factor acts as a survival factor for newly formed retinal vessels and has implications for retinopathy of prematurity[J]. Nature Medicine, 1995, 1(10):1024-1028.
|
[25] |
邵彦,李筱荣. 抗血管内皮生长因子药物治疗年龄相关性黄斑变性的现状[J]. 眼科,2007,16(4):282-284.
|
[26] |
孙晓东,宋正宇,汪枫桦. 抗血管内皮生长因子A药物治疗年龄相关性黄斑变性随访及再治疗的策略[J]. 中华实验眼科杂志,2012,30(5):385-387.
|
[27] |
Chen Y, Wiesmann C, Fuh G, et al. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity-matured fab in complex with antigen 1[J]. Journal of Molecular Biology, 1999, 293(4):865-881.
|
[28] |
Emerson MV, Lauer AK. Emerging Therapies for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema[J]. Biodrugs Clinical Immunotherapeutics Biopharmaceuticals & Gene Therapy, 2007, 21(4):245-257.
|
[29] |
Lu X, Sun X. Profile of conbercept in the treatment of neovascular age-related macular degeneration[J]. Drug Design Development & Therapy, 2015, 9(2):2311-2320.
|
[30] |
Pauleikhoff D, Kirchhof B, Bertram B, et al. New aspects in the treatment of neovascular age-related macular degeneration: the criteria of re-treatment with the anti-VEGF therapy[J]. Der Ophthalmologe, 2011, 108(1):85-90.
|
[31] |
Papadopoulos N, Martin J, Ruan Q, et al. Binding and neutralization of vascular endothelial growth factor (VEGF) and related ligands by VEGF Trap, ranibizumab and bevacizumab[J]. Angiogenesis, 2012, 15(2):171-185.
|
[32] |
Spilsbury K, Garrett KL, Shen WY, et al. Overexpression of Vascular Endothelial Growth Factor (VEGF) in the Retinal Pigment Epithelium Leads to the Development of Choroidal Neovascularization[J]. American Journal of Pathology, 2000, 157(1):135-144.
|
[33] |
钱彤,黎晓新,尹虹,等. 玻璃体腔注射avastin治疗视网膜分支静脉阻塞继发黄斑水肿疗效观察[J]. 中华实验眼科杂志,2010,28(1):79-82.
|
[34] |
王馨. 玻璃体腔注射雷珠单抗联合曲安奈德或激光光凝治疗视网膜分支静脉阻塞继发黄斑水肿疗效观察[J]. 中国实用医药,2017,12(2):110-112.
|
[35] |
宋莉,沙翔垠,郑瑜,等. 康柏西普治疗视网膜分支静脉阻塞继发黄斑水肿疗效分析[J]. 广东医学,2017,38(5):778-780.
|
[36] |
Singer MA, Cohen SR, Groth SL, et al. Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions[J]. Clinical Ophthalmology, 2013, 7(1):1377-1383.
|
[37] |
Gerding H. Results of a Meta-Analysis on Intravitreal anti-VEGF Treatment of Macular Oedema Secondary to Branch Retinal Vein Occlusion (BRVO)[J]. Klin Monatsbl Augenheilkd, 2017, 234(4):551-555.
|
[38] |
Gerding H. Intravitreal anti-VEGF Treatment in Central Retinal Vein Occlusion (CRVO): a Meta-Analysis of One Year Results[J]. Klinische Monatsblatter Fur Augenheilkunde, 2017, 234(4):546-550.
|
[39] |
Tsai RYL. Balancing self-renewal against genome preservation in stem cells: How do they manage to have the cake and eat it too?[J]. Cellular & Molecular Life Sciences, 2016, 73(9):1803-1823.
|
[40] |
Tsai RYL. A molecular view of stem cell and cancer cell self-renewal[J]. International Journal of Biochemistry & Cell Biology, 2004, 36(4):684-694.
|